The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease

Abroad (travel likely)Recruiting

Conditions

Alzheimer's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Xuanwu Hospital of Capital Medical University, Beijing, Beijing Municipality, China
Contact: Study coordinator (Jianping Jia, Doctor) · jiajp@vip.126.com · 8610-83199449

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease

AD · Early Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE2

Chongqing, China

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)

Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE1

Montreal, Canada · Amsterdam, Netherlands

TREAD: Time Restricted Eating Intervention for Alzheimer's Disease

Mild Cognitive Impairment · Alzheimer Disease · Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE1

San Diego, United States

Social & Affective Cognition in Alzheimer's Disease & Associated Disorders

Alzheimer's Disease · Frontotemporal Degeneration (Semantic & Behavioral Variants)

Abroad (travel likely)Recruiting

Lille, France